Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)

BACKGROUND: Atezolizumab combined with bevacizumab plus platinum-based chemotherapy is a standard treatment for advanced non-squamous non-small-cell lung cancer (nsNSCLC). We aimed to determine the most effective platinum-based combination, such that future studies with atezolizumab can be conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Udagawa, Hibiki, Sugiyama, Eri, Harada, Toshiyuki, Atagi, Shinji, Koyama, Ryo, Watanabe, Satoshi, Nakamura, Yukiko, Harada, Daijiro, Hataji, Osamu, Tanaka, Fumihiro, Kida, Hiroshi, Satouchi, Miyako, Maeno, Ken, Inoue, Akira, Yoh, Kiyotaka, Yamane, Yuki, Urata, Yoshiko, Yoshioka, Hiroshige, Yamanaka, Takeharu, Goto, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350093/
https://www.ncbi.nlm.nih.gov/pubmed/34430347
http://dx.doi.org/10.21037/tlcr-21-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350093/
https://www.ncbi.nlm.nih.gov/pubmed/34430347
http://dx.doi.org/10.21037/tlcr-21-240

Ejemplares similares